Fast-Growing Oncology Startup OncoLens Secures $7.25 Million Series A Funding


OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced today that it has raised a $7.25 million Series A investment from BIP Capital, Martin Ventures, and SeedToB Capita...

Read More +

NCI designated VCU Massey Cancer Center signs with OncoLens


Massey Cancer Center, an NCI designated cancer institute, has a strong focus on advancing clinical research and care collaboration within the Virginia community. OncoLens is proud to announce that VCU...

Read More +

Inova Schar Cancer Institute to utilize OncoLens for care treatment planning at its tumor boards


Inova Schar Cancer has chosen the OncoLens platform as a tool to streamline their tumor boards or multi-disciplinary cancer conferences, but more importantly align care among their seven hospitals. I...

Read More +